|
|
||||
23/01/2026 08:01
SWEF: Dividend Declaration
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= cellpadding= cellspacing= trtd
p
Starwood European Real Estate Finance Ltd SWEF
br/
SWEF: Dividend Declaration br/br/span23Jan2026 / 07:01 GMT/BST/spanbr/br//p
hr/divdiv
p...
Lire...
23/01/2026 08:00
SWEF: December 2025 NAV
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= cellpadding= cellspacing= trtd
p
Starwood European Real Estate Finance Ltd SWEF
br/
SWEF: December 2025 NAV br/br/span23Jan2026 / 07:00 GMT/BST/spanbr/br//p
hr/divdiv
p...
Lire...
23/01/2026 08:00
Molten Ventures Plc : Transaction in Own Shares
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= cellpadding= cellspacing= trtd
p
Molten Ventures Plc GROW
br/
Transaction in Own Shares br/br/span23Jan2026 / 07:00 GMT/BST/spanbr/br//p
hr/divp style=margintop:0pt; marginbottom:0pt;...
Lire...
PRESS RELEASE
Transgene Further Strengthens
Scientific Advisory Board with Appointments
of Renowned Cancer Immunotherapy Experts
Antoine Italiano and Ignacio Melero
Strasbourg, France, January 23, 2026, 8:00 a.m. CET – Transgene Euronext Paris: TNG, a
biotech company that designs and...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pMikron Holding AG / Key words: Development of Salesbr/
Mikron reports net sales of CHF 381.9 million for 2025 br/br/
23Jan2026 / 07:00 CET/CESTbr/
Release of an ad hoc announcement pursuant to Art. 53...
Lire...
23/01/2026 07:00
Reinet Investments SCA : MANAGEMENT STATEMENT FOR THE THIRD QUARTER ENDED 31 DECEMBER 2025
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pReinet Investments SCA / Key words: Quarter Resultsbr/
MANAGEMENT STATEMENT FOR THE THIRD QUARTER ENDED 31 DECEMBER 2025 br/br/
23Jan2026 / 07:00 CET/CESTbr/
Release of an ad hoc announcement pursuant to Art....
Lire...
23/01/2026 07:00
EQS-Adhoc: BB Biotech AG closes the 2025 fiscal year with a profit
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pEQSAdhoc: BB BIOTECH AG / Key words: Annual Resultsbr/
BB Biotech AG closes the 2025 fiscal year with a profit br/br/
23Jan2026 / 07:00 CET/CESTbr/
Disclosure of an inside information acc. to Article...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: BB BIOTECH AG
/ Key words: Annual Results/Dividend
br/
BB Biotech: Preliminary fullyear 2025 results and dividend proposal br/br/
23.01.2026 / 07:00...
Lire...
Press Release
Sanofis amlitelimab confirms its potential in atopic
dermatitis
• In the SHORE phase 3 study, amlitelimab in combination with topical therapies met all
primary and key secondary endpoints at Week 24 with efficacy progressively increasing
throughout the treatment...
Lire...
|
|
||||